Navigation Links
Ambien and the Other Insomnia Drugs

Ambien is produced and marked by Sanofi-Aventis. It is one of the leading insomnia drug companies. But at present it is in great trouble as its drug is going to go// off-patent this October. There's a range of insomnia drugs on the market, and more are on the way. This is a great relief for some of the people who depend on Ambien for a good night’s sleep.

Good news has been in short supply for the French pharmaceutical company of late. A string of media reports recently highlighted the links between Ambien and sleepwalking, binge eating, and even dangerous nighttime driving.

The side effects though already known and mentioned on the product label are attracting increased attention. It’s just a matter of time before cheaper generic versions of insomnia drugs hit the market. Sanofi-Aventis is hoping to withstand some of the threat. Ambien has the lion's share of the $2 billion prescription insomnia drug market.

Sepracor's Lunesta, available since last April, accounts for about 10%. The drug raked in $329.2 million in its first few months. According to National Sleep Foundation (NSF) it was found that 6 out of l0 people approximately about 126 million people experience at least one symptom of insomnia a few nights a week.

But at present Ian Anderson, an analyst at Cowen & Co, says that only 16% of the patient population is being treated with drug therapy. He also predicts that the market would grow up to 30% this year. Indiplon, created by Pfizer and Neurocrine Biosciences is expected to hit the markets this autumn but their approval by the Food & Drug Administration is pending.

The drug will come in two forms. The short-acting version is meant to help treat jetlag and other short-term sleep needs, such as waking up in the middle of the night. Indiplon's relatively short half-life reduces the hangover-like effect, particularly for people who use the drug in the middle of the night.

But Ambien and Lunesta b oth have longer half-lives, so they are typically not used as middle-of-the-night solutions. But the drug companies have recently asked each other not to begin TV and print advertising of new prescription medicine until physicians have had at least six months to learn more about them.

This is because they feel that ads would generate more immediate interest in a drug. The waiting period is aimed at fostering dialogue between patients and their physicians. It could mean patients will make more informed choices about prescription drugs.


'"/>




Related medicine news :

1. Aromatherapy: Ambient odors of orange and lavender reduce anxiety
2. Ambien Plus Alcohol Has A Bad Influence on the Drivers
3. Tune Your Brain to Hear Another in a Noisy Ambience
4. FDA Approves First Generic Versions of Ambien for Insomnia
5. Twins Less Prone to Suicide Than Others
6. Sleep Disorders Could Indicate Other Medical Problems
7. Features Of The Brain Affect Asthma And Other Stress Related Disorders
8. Smokers Avoid Dental Care More Than Others
9. Brain Patterns In Amusia May Be Related To Other Disorders
10. Genetic Eye Disorder Can Have Other Implications
11. Some See A Hopeless End, While Others See An Endless Hope
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/29/2016)... Ferry, New York (PRWEB) , ... April 30, 2016 , ... ... the Dobbs Ferry campus. The following programs will be expanding due to high ... Management (HRM). The expansion will begin this summer. , School of ...
(Date:4/29/2016)... ... April 29, 2016 , ... Shamangelic Healing, ... addition Onnit brand Alpha BRAIN and New Mood Daily-Stress Formula for brain optimization ... optimization products to the store is just one more way Shamangelic Healing supports ...
(Date:4/29/2016)... , ... April 29, 2016 , ... ... healthcare awareness and author of best seller "LOVE, MEDICINE and MIRACLES") addresses touchy ... May 2, 2016 and podcasted thereafter . Dr. Bernie Siegel, author of ...
(Date:4/29/2016)... ... April 29, 2016 , ... A new study ... severe congenital diaphragmatic hernia have better survival rates if surgery is performed early. ... condition where the diaphragm fails to form completely, letting abdominal organs into the ...
(Date:4/29/2016)... ... April 29, 2016 , ... World Patent Marketing ... an exercise invention which aids in proper muscle development. , "The Gym & ... Creative Director of World Patent Marketing. "Globalization has threatened the future growth of ...
Breaking Medicine News(10 mins):
(Date:4/29/2016)... April 29, 2016 ... Financier Sanofi, leader mondial ... ses résultats pour le premier trimestre ... Jérôme Contamine, commente les résultats du ... perspectives pour le reste de l,année. ...
(Date:4/28/2016)... , April 28, 2016  While Abbott,s announced ... the company,s valve repair and stent business, healthcare ... places Abbott more firmly into patient monitoring.  Kalorama ... fastest growing device areas, with double-digit growth expected ... report,  Advanced Remote Patient Monitoring . ...
(Date:4/28/2016)... -- The blood testing market in China ... and The Freedonia Group in a recent report.  The ... healthcare research firm said that China ... and in improving testing at the provincial level.   The ... Blood Testing Market in China , which utilized ...
Breaking Medicine Technology: